| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/22/2005 | WO2005031362A3 Novel antibacterial agents and methods of identifying and utilizing same |
| 09/22/2005 | WO2005027830A3 Chimeric transcription factor decoy oligonucleotides |
| 09/22/2005 | WO2005014825A3 Methods of protein production in yeast |
| 09/22/2005 | WO2005014786A3 Enhanced engineered chromosome formation from alpha satellite with artificially increased density of cenp-b boxes |
| 09/22/2005 | WO2004105466A3 Floral transformation |
| 09/22/2005 | WO2004104174A3 Polyubiquitin rubi3 promoter and 5' regulatory sequences |
| 09/22/2005 | WO2004092345A3 Transformation of brassica |
| 09/22/2005 | WO2004065620A3 Modulation of thyroid hormone receptor interactor 3 expression |
| 09/22/2005 | WO2004058147A3 Human chondroitinase glycoprotein (chasegp), process for preparing the same, and pharmaceutical compositions comprising thereof |
| 09/22/2005 | WO2004050939A3 Plasma-assisted melting |
| 09/22/2005 | WO2004047741A3 Modulation of iap-like expression |
| 09/22/2005 | WO2000075279A3 Nucleotide sequences for gene regulation and methods of use thereof |
| 09/22/2005 | US20050210549 Sesquiterpene synthases and methods of use |
| 09/22/2005 | US20050210548 Hydrolase expressed in transgenic plants for improving feed digestibility in baking and brewing |
| 09/22/2005 | US20050210547 Plant control genes |
| 09/22/2005 | US20050210546 Generation of plants with improved pathogen resistance |
| 09/22/2005 | US20050210545 Expression vector comprising nucleotide sequences coding insecticidal proteins for use in transformation and propagation of insect resistant crop plants; biological pest control |
| 09/22/2005 | US20050210544 Using vector transformation of nucleotide sequences coding S-phase specific ribosomal protein (S3A) as tool in enhancing propagation of crop plants |
| 09/22/2005 | US20050210543 Expression vector comprising nucleotide sequences coding restriction enzyme for use as tool in generation of insertional mutations among related polynucleotides, via vitro heteroduplex molecule formation |
| 09/22/2005 | US20050210542 relates to seeds, plants of soybean 0509214 and to methods for producing soybean plant by crossing soybean 0509214 with itself or another soybean line, and the creation of variants by mutagenesis or transformation of soybean 0509214; tolerance to glyphosate; lodging resistance |
| 09/22/2005 | US20050210540 Expression vector comprising nucleotide sequence coding glycine transport protein for use in generating animal models which identify modulators of psychotic behavior |
| 09/22/2005 | US20050210539 Methods of preforming homologous recombination based modification of nucleic acids in recombination deficient cells and use of the modified nucleic acid products thereof |
| 09/22/2005 | US20050210538 Screening for a developmental promoter or a developmental suppressor of oligodendrocytes, or a promoter or a suppressor of myelinogenesis, diagnostic for neuropsychiatric disorders |
| 09/22/2005 | US20050210537 Using cardiomyocyte nuclear transplantion in generation of hybrid cells |
| 09/22/2005 | US20050209448 Secretion, transcription and sporulation genes in bacillus clauslii |
| 09/22/2005 | US20050209280 Diagnostic agent, method for detecting a carcinoma, and means for the treatment thereof |
| 09/22/2005 | US20050209201 allowing an ATP receptor antagonist ( Reactive Blue 2 ) to work on ATP receptors of cells to block them and thereby inhibit the release of inflammatory cytokines, particularly interleukin-6 (IL-6) and/or interleukin-8 (IL-8) |
| 09/22/2005 | US20050209182 Inhibits bacterial subtilisn type serine protease CylA activity; siRNA, antisense, and enzymatic nucleic acid molecules that can modulate the expression of CylA genes |
| 09/22/2005 | US20050209179 chemically synthesized double stranded siNA that directs cleavage of an amyloid precursor protein (APP) RNA |
| 09/22/2005 | US20050209178 Methods and compositions for the treatment of obesity |
| 09/22/2005 | US20050209161 Drugs for treatment of inflammation/blood brain barrier degradation;administering to a subject in need of such treatment, a pharmaceutically effective amount of a peptide antagonist of zonulin, wherein the peptide antagonist binds to a zonula occludens toxin receptor |
| 09/22/2005 | US20050209140 Methods of controlling axonal growth |
| 09/22/2005 | US20050208675 Preparing biochip support via applying droplets of liquid sample, containing biological substance, to plurality of positions on surface of water repellent substrate using ink-jet microarrayer |
| 09/22/2005 | US20050208662 Enterobacteriaceae fermentation strains |
| 09/22/2005 | US20050208661 Viral plasmid for use as tool in heterologous gene transfer; gene therapy |
| 09/22/2005 | US20050208660 Infecting a eukaryotic cell with a vactor system having DNA segment from a BIV genome; a packaging sequence to package RNA into virions; a first promoter operably linked to the DNA segment; d) a transgene operably linked to a second promoter and deletion of vpw, vpy and tat from the construct |
| 09/22/2005 | US20050208659 Using adenoviral transformation/transfection to transfer cyclin and cyclin dependent kinase genes into nucleus of differentiated cells; regenerative medicine and tissue engineering |
| 09/22/2005 | US20050208658 RNA interference mediated inhibition of 11beta hydroxysteriod dehydrogenase-1 (11beta HSD-1) gene expression |
| 09/22/2005 | US20050208657 Delivery of functional protein sequences by translocating polypeptides |
| 09/22/2005 | US20050208645 Electrofusion microelectrode |
| 09/22/2005 | US20050208640 Using transferase polypeptide in diagnosis, prevention and treatment of cell proliferative disorders; cosmetics; nutraceuticals |
| 09/22/2005 | US20050208636 Saccharomyces cerevisiae mutant |
| 09/22/2005 | US20050208635 Synthesizing on base material polyhydroxyalkanoate using 3-hydroxyacyl coenzyme A as substrate; color filters; static charge image developing toner; electrophoresis; inks |
| 09/22/2005 | US20050208634 nucleotides that code proteins involved in one-carbon compounds metabolism, derived from microorganisms belonging to methylotrophic bacteria |
| 09/22/2005 | US20050208633 Sugar kinases with expanded substrate specificity and their use |
| 09/22/2005 | US20050208632 Method for producing 2'-deoxyribonucleoside |
| 09/22/2005 | US20050208631 Polypeptide of N-acetylglucosamine-6-O-sulfotransferase and DNA encoding the same |
| 09/22/2005 | US20050208629 Plasmids for polyketide production |
| 09/22/2005 | US20050208628 Methods and vectors for generating antibodies in avian species and uses therefor |
| 09/22/2005 | US20050208625 Monoclonal antibodies with reduced immunogenicity |
| 09/22/2005 | US20050208624 Fluorescent protein |
| 09/22/2005 | US20050208623 Expression of granular starch hydrolyzing enzyme in Trichoderma |
| 09/22/2005 | US20050208619 29 human secreted proteins |
| 09/22/2005 | US20050208617 Human-like glycoproteins; for hydrolysis of oligosaccharide substrates for N-glycan processing in secretory pathway |
| 09/22/2005 | US20050208616 Method and materials for producing deletion derivatives of polypeptides |
| 09/22/2005 | US20050208610 Method of producing an anticoagulation effect |
| 09/22/2005 | US20050208605 An antibody or fragment (especially a monoclonal antibody) that binds to specific antigens for use in the diagnosis and treatment of heart, kidney and inflammatory diseases |
| 09/22/2005 | US20050208601 Using f-box containing protein as tool in treatment and prevention of infection, cardiovascular, cell proliferative and nervous system disorders |
| 09/22/2005 | US20050208596 Compositions, methods and kits relating to anti-platelet autoantibodies and inhibitors thereof |
| 09/22/2005 | US20050208591 Antibodies to chemokine alpha-6 |
| 09/22/2005 | US20050208581 Heat resistant polymerase for use in cyclic DNA amplification |
| 09/22/2005 | US20050208580 Novel protein and method for producing the protein |
| 09/22/2005 | US20050208578 Isolated human aminoacylase, nucleic acid molecules encoding human aminoacylase, and uses thereof |
| 09/22/2005 | US20050208577 Using reporter molecule expression as diagnostic tool in monitoring interacting sets of molecules |
| 09/22/2005 | US20050208576 Sorting and immobilization system for nucleic acids using synthetic binding systems |
| 09/22/2005 | US20050208569 Human stanniocalcin-alpha |
| 09/22/2005 | US20050208566 Using enzymatic membrane protein as tool in identifying modulators for prevention and treatment of atherosclerotic, inflammatory and cell proliferative disorders |
| 09/22/2005 | US20050208565 29 human cancer associated proteins |
| 09/22/2005 | US20050208564 Recombinant DNA processes using a dNTP mixture containing modified nucleotides |
| 09/22/2005 | US20050208561 Method for evaluating DNA probes position on substrate |
| 09/22/2005 | US20050208560 Using immunoglobulins to identify staphylococcal peptides associated with viriginiamycin resistant |
| 09/22/2005 | US20050208559 directed toward modulating oxidative damage to intracellular components such as mitochondrial DNA (mtDNA) and mitochondrial protein; antibody, or fragment thereof, that specifically binds to enzyme |
| 09/22/2005 | US20050208557 Using polyphospate label as tool in genic sequencing; conducting a nucleic acid polymerase reaction to produce labeled polyphosphate which are then analyzed |
| 09/22/2005 | US20050208552 Corpuscles of Stannius protein, stanniocalcin |
| 09/22/2005 | US20050208551 Novel PRKAG3 alleles and use of the same as genetic markers for reproductive and meat quality traits |
| 09/22/2005 | US20050208549 Using gene expression variation in organelles as diagnostic tool in detection and evaluation of metabolic disorders; drug screening and side effect reduction |
| 09/22/2005 | US20050208548 Method and device for purifying nucleic acids |
| 09/22/2005 | US20050208546 Nucleotide sequences coding tumor associated antigens for use as tool in diagnosis, prevention and treatment of cell proliferative disorders |
| 09/22/2005 | US20050208544 Diagnostic tests for the detection of peripheral neuropathy |
| 09/22/2005 | US20050208540 Novel fibroblast growth factor and nucleic acids encoding same |
| 09/22/2005 | US20050208536 Comprises ribonuclease barnase marker gene; libraries; drug resistance |
| 09/22/2005 | US20050208533 Modulators of morphogen expression and methods of identifying the same |
| 09/22/2005 | US20050208532 Compositions and their uses directed to signal transducers |
| 09/22/2005 | US20050208530 Using recombination reaction, primer extension and dideoxynucleotides to sequence all or part of a nucleic acid segment |
| 09/22/2005 | US20050208526 Polypeptides, fragments and homologues; vectors, host cells, antibodies; genetic engineering and expression; treatment of urogenital, sexual, metabolic, inflammatory, pregnancy, and g-protein coupled receptor disorders; drug screening |
| 09/22/2005 | US20050208525 Nucleotide sequences coding preferential polypeptide for use in the treatment defects in immune and inflammatory response |
| 09/22/2005 | US20050208524 Full-length expressed genetic marker (FLEXGEM) polypeptide for use as diagnostic indicator of cell proliferative disorders |
| 09/22/2005 | US20050208523 Compositions and methods for the diagnosis and treatment of tumor |
| 09/22/2005 | US20050208522 Fibroblast growth factor-like molecules and uses thereof |
| 09/22/2005 | US20050208521 Modulation signal transduction; isolated nucleic acids; genetic engineering |
| 09/22/2005 | US20050208520 Polynucleotide sequences encoding alkaline alpha-galactosidases and methods of using same |
| 09/22/2005 | US20050208517 Using plurality of probes to identify sequence variation associated with sickle cell anemia |
| 09/22/2005 | US20050208515 Method of DNA shuffling with polynucleotides produced by blocking or interrupting a synthesis or amplification process |
| 09/22/2005 | US20050208510 Modified surfaces as solid supports for nucleic acid purification |
| 09/22/2005 | US20050208508 Gene encoding labyrinthin, a marker for cancer |
| 09/22/2005 | US20050208507 Human RPS6KA6-related gene variant associated with lung cancers |
| 09/22/2005 | US20050208496 Using enhanced interleukin gene expression as diagnostic indicator of respiratory system disorders |
| 09/22/2005 | US20050208495 Real-time detection of nucleic acid reactions |
| 09/22/2005 | US20050208492 Regulation of human serine/threonine kinase |
| 09/22/2005 | US20050208490 Ligand binding pocket peptide fragment of estrogen-related receptor 3 (err3) and uses thereof |